Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

Clinical and Experimental Rheumatology

Volumn 29, Issue 4 SUPPL. 67, 2011, Pages

  Olivieri, I ^a   Leccese, P ^a   D'Angelo, S ^a,b   Padula, A ^a   Nigro, A ^a   Palazzi, C ^a   Coniglio, G ^c   Latanza, L ^d  

^a SAN CARLO HOSPITAL   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c Ospedale Civile di Matera   (Italy)

^d CARDARELLI HOSPITAL   (Italy)

Author keywords

Adalimumab; Beh et's disease; Infliximab; Neuro Beh et's disease; TNF a antagonists

Indexed keywords

ADALIMUMAB; INFLIXIMAB; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INTERFERON; METHOTREXATE; PREDNISONE; THALIDOMIDE;

ARTICLE; BEHCET DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA VASCULITIS; ADULT; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; INFUSION RELATED REACTION; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; REMISSION; SKIN DEFECT; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG ADULT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BEHCET SYNDROME; DRUG RESISTANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80855144525     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1657-62.
2. SFIKAKIS PP, MARKOMICHELAKIS N, ALPSOY E et al.: Anti-TNF therapy in the management of Behçet's disease - review and basis for recommendations. Rheumatology (Oxford) 2007; 46: 736-41. (Pubitemid 47061701)
3. PIPITONE N, OLIVIERI I, PADULA A et al.: Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum 2008; 59: 285-90. (Pubitemid 351272967)
4. VAN LAAR JA, MISSOTTEN T, VAN DAELE PL, JAMNITSKI A, BAARSMA GS, VAN HAGEN PM: Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis 2007; 66: 565-6. (Pubitemid 46580490)
5. BELZUNEGUI J, LÓPEZ L, PANIAGUA I, INTXAUSTI JJ, MAfz O: Efficacy of inflixi-mab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S133-4.
6. TAKASE K, OHNO S, IDEGUCHI H, UCHIO E, TAKENO M, ISHIGATSUBO Y: Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis. Rheumatol Int 2011; 31: 243-5.
7. BAWAZEER A, RAFFA LH: Clinical experience with adalimumab in the treatment of ocular Behçet disease. Ocul Immunol Inflamm 2010; 18: 226-32.
8. ARIDA A,FRAGIADAKI K,GIAVRI E,SFIKAKIS PP: Anti-TNF agents for Behçet's Disease: Analysis of published data on 369 patients. Semin Arthritis Rheum 2011; 41: 61-70.
9. INTERNATIONAL STUDY GROUP FOR Behçet's DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
10. OLIVIERI I, D'ANGELO S, PADULA A, LECCESE P, MENNILLO GA: Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S112.
11. BENEZRA D, FORRESTER JV, NUSSENBLATT RB, TABBARA K, TIMONEN P: Uveitis Scoring System. Berlin, Springer Publisher 1991.
12. ATZENI F, LECCESE P, D'ANGELO S, SARZIPUTTINI P, OLIVIERI I: Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab. Clin Exp Rheumatol 2010; 28 (Suppl. 60): S94.
13. LECCESE P, LATANZA L, D'ANGELO S, PADULA A, OLIVIERI I: Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Clin Exp Rheumatol 2011; 29 (Suppl. 67): S93.
14. LECCESE P, D'ANGELO S, PADULA A, CONIGLIO G, OLIVIERI I: Switching to adalimumab in a case of Neuro-Behçet's disease refractory to infliximab. Clin Exp Rheumatol 2010; 28 (Suppl. 60): 102.
15. OLIVIERI I, LATANZA L, SIRINGO S, PERUZ G, Di IORIO V: Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete. J Rheumatol 2008; 35: 930-2. (Pubitemid 351747140)
16. OLIVIERI I, PADULA A, LECCESE P, D'ANGELO S, GIASI V: Long-lasting remission of severe Behçet's disease after the end of infliximab therapy. J Rheumatol 2009; 36: 855.